BACKGROUND: Pseudomonas aeruginosa with mutations in the transcriptional regulator LasR chronically infect the airways of people with cystic fibrosis (CF), yet the prevalence and clinical implications of lasR mutant infection are unknown. METHODS: In an exploratory study, we screened 166 P. aeruginosa isolates from 58 CF patients for LasR inactivation and mucoidy, and compared clinical characteristics among source patients. RESULTS: lasR mutation prevalence was comparable to that of mucoidy, the best-described CF-adapted phenotype, but affected patients were on average approximately 2 years younger. In a regression analysis, lung function decline with age was worse among patients with lasR mutant infection than in those without, similar to the effect of mucoidy. CONCLUSIONS: Culture positivity for lasR mutant P. aeruginosa may serve as a marker of early CF adaptive change of prognostic significance. Furthermore, as LasR inactivation alters susceptibility to antibiotics, infection with lasR mutant P. aeruginosa may impact response to therapy.
BACKGROUND:Pseudomonas aeruginosa with mutations in the transcriptional regulator LasR chronically infect the airways of people with cystic fibrosis (CF), yet the prevalence and clinical implications of lasR mutant infection are unknown. METHODS: In an exploratory study, we screened 166 P. aeruginosa isolates from 58 CF patients for LasR inactivation and mucoidy, and compared clinical characteristics among source patients. RESULTS:lasR mutation prevalence was comparable to that of mucoidy, the best-described CF-adapted phenotype, but affected patients were on average approximately 2 years younger. In a regression analysis, lung function decline with age was worse among patients with lasR mutant infection than in those without, similar to the effect of mucoidy. CONCLUSIONS: Culture positivity for lasR mutant P. aeruginosa may serve as a marker of early CF adaptive change of prognostic significance. Furthermore, as LasR inactivation alters susceptibility to antibiotics, infection with lasR mutant P. aeruginosa may impact response to therapy.
Authors: Morten Hentzer; Hong Wu; Jens Bo Andersen; Kathrin Riedel; Thomas B Rasmussen; Niels Bagge; Naresh Kumar; Mark A Schembri; Zhijun Song; Peter Kristoffersen; Mike Manefield; John W Costerton; Søren Molin; Leo Eberl; Peter Steinberg; Staffan Kjelleberg; Niels Høiby; Michael Givskov Journal: EMBO J Date: 2003-08-01 Impact factor: 11.598
Authors: J L Burns; R L Gibson; S McNamara; D Yim; J Emerson; M Rosenfeld; P Hiatt; K McCoy; R Castile; A L Smith; B W Ramsey Journal: J Infect Dis Date: 2000-12-27 Impact factor: 5.226
Authors: J Andy Schaber; Nancy L Carty; Naomi A McDonald; Eric D Graham; Rajkumar Cheluvappa; John A Griswold; Abdul N Hamood Journal: J Med Microbiol Date: 2004-09 Impact factor: 2.472
Authors: Susan E H West; Lan Zeng; Bee Leng Lee; Michael R Kosorok; Anita Laxova; Michael J Rock; Mark J Splaingard; Philip M Farrell Journal: JAMA Date: 2002-06-12 Impact factor: 157.335
Authors: Michelle E Clay; John H Hammond; Fangfang Zhong; Xiaolei Chen; Caitlin H Kowalski; Alexandra J Lee; Monique S Porter; Thomas H Hampton; Casey S Greene; Ekaterina V Pletneva; Deborah A Hogan Journal: Proc Natl Acad Sci U S A Date: 2020-01-24 Impact factor: 11.205
Authors: Vanessa E Rees; Deanna S Deveson Lucas; Carla López-Causapé; Yuling Huang; Tom Kotsimbos; Jürgen B Bulitta; Murray C Rees; Adele Barugahare; Anton Y Peleg; Roger L Nation; Antonio Oliver; John D Boyce; Cornelia B Landersdorfer Journal: Antimicrob Agents Chemother Date: 2019-03-27 Impact factor: 5.191
Authors: Nicole Mayer-Hamblett; Margaret Rosenfeld; Ronald L Gibson; Bonnie W Ramsey; Hemantha D Kulasekara; George Z Retsch-Bogart; Wayne Morgan; Daniel J Wolter; Christopher E Pope; Laura S Houston; Bridget R Kulasekara; Umer Khan; Jane L Burns; Samuel I Miller; Lucas R Hoffman Journal: Am J Respir Crit Care Med Date: 2014-08-01 Impact factor: 21.405
Authors: Lucas R Hoffman; Anthony R Richardson; Laura S Houston; Hemantha D Kulasekara; Willm Martens-Habbena; Mikkel Klausen; Jane L Burns; David A Stahl; Daniel J Hassett; Ferric C Fang; Samuel I Miller Journal: PLoS Pathog Date: 2010-01-08 Impact factor: 6.823